SCHEMBL3475375

SCHEMBL3475375

Nc1ncccc1-c1nc2ccccc2o1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.58
RAB9A P51151 6/20 0.58
ALDH1A1 P00352 6/20 0.58
HSD17B10 Q99714 6/20 0.58
KDM4E B2RXH2 6/20 0.58
TP53 P04637 6/20 0.58
SMN1; SMN2 Q16637 5/20 0.58
HPGD P15428 5/20 0.58
CYP1A2 P05177 1/20 0.58
CYP2C9 P11712 1/20 0.58
CYP2C19 P33261 1/20 0.58
MET P08581 4/20 0.58
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
ATM Q13315 1/20 0.53
PKM P14618 3/20 0.49
TOP2A P11388 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
MAPT P10636 6/20 0.48
GAA P10253 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12076627 0.83 KDM4E (0.62) NPC1RAB9AALDH1A1HSD17B10KDM4E
SCHEMBL16581490 0.82 KDM4E (0.60) NPC1RAB9AALDH1A1HSD17B10KDM4E
SCHEMBL29504749 0.80 TOP2A (0.62) NPC1RAB9AALDH1A1HSD17B10KDM4E
SCHEMBL171055 0.80 TOP2A (0.62) NPC1RAB9AALDH1A1HSD17B10KDM4E
SCHEMBL30132417 0.80 ATM (0.61) NPC1RAB9AALDH1A1HSD17B10KDM4E
SCHEMBL2381205 0.80 ATM (0.61) NPC1RAB9AALDH1A1HSD17B10KDM4E
SCHEMBL16005595 0.79 ALDH1A1 (0.60) NPC1RAB9AALDH1A1HSD17B10KDM4E
SCHEMBL2386939 0.79 NPC1 (0.56) NPC1RAB9AALDH1A1HSD17B10KDM4E
SCHEMBL12854009 0.79 TOP2A (0.60) NPC1RAB9AALDH1A1HSD17B10KDM4E
SCHEMBL2388942 0.79 MET (0.65) NPC1RAB9AALDH1A1HSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2215085-A2 PYRIDINE AND PYRAZINE DERIVATIVES USEFUL IN THE TREATMENT OF CELL PROLIFERATIVE DISORDERS AstraZeneca AB (SE) 2010-08-11 EP disclosed
WO-2009053737-A2 PYRIDINE AND PYRAZINE DERIVATIVES USEFUL IN THE TREATMENT OF CELL PROLIFERATIVE DISORDERS ASTRAZENECA AB (SE) 2009-04-30 WO disclosed